i.Why did Imprimis offer to sell the product for only $1/pill?

ii.What would be the consequences of the FDA permitting international imports of Daraprim and the mass manufacturing of Daraprim by Imprimis?Assuming perfect competition, what is the value of consumer surplus after eliminating barriers to entry the market?

iii.What are the costs and benefits of an extensive FDA approval process for generic drugs?

iv.What is the responsibility of the CEO to the shareholders of Turing and to society?

v.Should Martin Shkreli lower the price of Daraprim?

p= -14.98Q+149,900

elasticity o demand= -1.0013

learner index = 0.9987

MC= 100

here are the information about the case study ( the most hated CEO in america)

\f\f\f\f\f\f\f\f